BioWorld

Feb. 25, 2003

View Archived Issues

VaxGen's AIDS Vaccine Comes Up Short; Blacks, Asians Show Benefit

VaxGen Inc. did not receive the results it and so many others hoped for after releasing Phase III trial data for its experimental AIDS vaccine, resulting in an investment backlash against the company's stock. (BioWorld Today) Read More

Trimeris, Roche Implement Program In Europe, Set Price

Read More

Monocyte Cells, Easily Accessible To Draw From Blood, Can Double For Dicey Embryonic Stem Cells

Read More

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Read More

Other News To Note

Read More

Appointments And Advancements

Read More